These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antihypertensive drugs and glucose metabolism. Rizos CV; Elisaf MS World J Cardiol; 2014 Jul; 6(7):517-30. PubMed ID: 25068013 [TBL] [Abstract][Full Text] [Related]
3. Metabolic effect of combined telmisartan and nifedipine CR therapy in patients with essential hypertension. Shimizu Y; Yamasaki F; Furuno T; Kubo T; Sato T; Doi Y; Sugiura T Int J Gen Med; 2012; 5():753-8. PubMed ID: 23049268 [TBL] [Abstract][Full Text] [Related]
4. A predictive model of the health benefits and cost effectiveness of celiprolol and atenolol in primary prevention of cardiovascular disease in hypertensive patients. Milne RJ; Vander Hoorn S; Jackson RT Pharmacoeconomics; 1997 Sep; 12(3):384-408. PubMed ID: 10170463 [TBL] [Abstract][Full Text] [Related]
5. Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertension. Maccario M; Oleandri SE; Avogadri E; Rossetto R; Grottoli S; Procopio M; Camanni F; Ghigo E J Endocrinol Invest; 1998 Jan; 21(1):56-63. PubMed ID: 9633024 [TBL] [Abstract][Full Text] [Related]
7. Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Wadworth AN; Murdoch D; Brogden RN Drugs; 1991 Sep; 42(3):468-510. PubMed ID: 1720383 [TBL] [Abstract][Full Text] [Related]
8. Choosing the correct drug for the individual hypertensive patient. Opie LH Drugs; 1992; 44 Suppl 1():147-55. PubMed ID: 1283579 [TBL] [Abstract][Full Text] [Related]
9. Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids. Fagerberg B; Berglund A; Andersson OK; Berglund G J Hypertens; 1992 Sep; 10(9):1053-61. PubMed ID: 1328365 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertension. Sheu WH; Swislocki AL; Hoffman B; Chen YD; Reaven GM Am J Hypertens; 1991 Mar; 4(3 Pt 1):199-205. PubMed ID: 2043298 [TBL] [Abstract][Full Text] [Related]
11. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. Pollare T; Lithell H; Selinus I; Berne C BMJ; 1989 Apr; 298(6681):1152-7. PubMed ID: 2500169 [TBL] [Abstract][Full Text] [Related]
12. Glucose and lipid metabolism in essential hypertension: effects of diuretics and ACE-inhibitors. De Cesaris R; Ranieri G; Filitti V; Andriani A; Lamontanara G Cardiology; 1993; 83(3):165-72. PubMed ID: 8281530 [TBL] [Abstract][Full Text] [Related]
13. Changes in glucose, insulin, lipid, lipoprotein, and apoprotein concentrations and insulin action in doxazosin-treated patients with hypertension. Comparison between nondiabetic individuals and patients with non-insulin-dependent diabetes mellitus. Maheux P; Facchini F; Jeppesen J; Greenfield MS; Clinkingbeard C; Chen YD; Reaven GM Am J Hypertens; 1994 May; 7(5):416-24. PubMed ID: 8060574 [TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. Pollare T; Lithell H; Mörlin C; Präntare H; Hvarfner A; Ljunghall S J Hypertens; 1989 Jul; 7(7):551-9. PubMed ID: 2668407 [TBL] [Abstract][Full Text] [Related]